Atlas Trials

Infection, Human Immunodeficiency Virus I

21 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Infection, Human Immunodeficiency Virus I

RecordFirmDate
A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ (NCT01597648)GlaxoSmithKline2011-11-01
A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects. (NCT01283100)ViiV Healthcare2011-03-01
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) (NCT01263015)ViiV Healthcare2011-02-01
ZIAGEN® Post-marketing Surveillance (NCT01205243)ViiV Healthcare2010-11-01
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily (NCT01227824)ViiV Healthcare2010-10-19
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects (NCT00549198)GlaxoSmithKline2007-06-01
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients (NCT00481390)GlaxoSmithKline2007-06-01
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults (NCT00450580)ViiV Healthcare2007-03-01
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection (NCT00440947)ViiV Healthcare2007-03-01
A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults (NCT00242879)ViiV Healthcare2005-08-01
Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects (NCT00197145)ViiV Healthcare2005-07-21
GW873140 In Combination With Combivir In HIV Infected Subjects (NCT00104429)ViiV Healthcare2005-01-01
Fosamprenavir Versus Other Protease Inhibitors (NCT00094523)ViiV Healthcare2004-12-14
GW873140 In Combination With Kaletra In HIV Infected Subjects (NCT00102778)ViiV Healthcare2004-12-01
GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults (NCT00257621)ViiV Healthcare2004-10-01
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection (NCT00089583)ViiV Healthcare2004-07-01
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV (NCT00082394)GlaxoSmithKline2004-04-26
Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir) (NCT00242840)ViiV Healthcare2003-06-01
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients (NCT00046176)ViiV Healthcare2002-08-26
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects (NCT00044577)ViiV Healthcare2002-07-16

Track Infection, Human Immunodeficiency Virus I automatically

Every clearance here is in the API, with alerts when new ones post.